photo
Speaker

Johan Verbeeck

VICE PRESIDENT, JBD ONCOLOGY, JOHNSON & JOHNSON
Titusville, New Jersey, United States
Johan Verbeeck is Vice President, Business Development, Oncology for Johnson & Johnson Innovation, Janssen Business Development. In this role, Johan leads the development and execution of all business development plans in support of Janssen’s Oncology Therapeutic Area. He oversees transactions and acquisitions, as well as scientific licensing and alliance management with strategic partners, with responsibility for bringing new compounds and businesses to Janssen.

Prior to his current position, Johan was Vice President, Business Development, Immunology for Johnson & Johnson Innovation, Janssen Business Development. In this role, Johan had accountability for all business development activities for this therapeutic area and has accountability for Immunology transactions, acquisitions, scientific licensing and alliance management. His team completed multiple transactions in this space, including the $6.5B acquisition of Momenta Pharmaceuticals in 2020.

Johan joined Johnson & Johnson in 1996, through Janssen Pharmaceutica in Belgium, in the Department of Animal Health and subsequently worked in Toxicology, where he became a Study Director for a multitude of small molecule development projects. He holds a Doctorate in Veterinary Medicine from the University of Gent, Belgium. He also graduated Cum Laude with a Master of Science in Applied Toxicology from the University of Surrey, United Kingdom.
Speaking In
8:30 AM - 10:00 AM (PDT)
Tuesday, June 14